
|Articles|October 1, 2001
Combination therapy may be answer for CTCL
Anaheim, Calif. - Combination therapy with biological responsemodifiers and careful and regular reassessment of refractory patients areof paramount importance in the effective treatment of cutaneous T-cell lymphoma,according to Carmela C. Vittorio, M.D.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Digital Twins in Dermatology: Your Patient’s Virtual Double Is Coming
2
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
3
Quality of Life in CSU Shaped by More Than Skin Symptoms
4
Filling the HS Treatment Gap: Ruxolitinib Targets Early-Stage Disease
5














